A5004444944- Advanced Radiotherapy Techniques
- Endometrial and Cervical Cancer Treatments
- Colorectal and Anal Carcinomas
- Breast Cancer Treatment Studies
- Management of metastatic bone disease
- Lung Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
- Ovarian cancer diagnosis and treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Breast Lesions and Carcinomas
- Pancreatic and Hepatic Oncology Research
- Glioma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Medical Imaging Techniques and Applications
- Economic and Financial Impacts of Cancer
- Esophageal Cancer Research and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Radiation Therapy and Dosimetry
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cervical Cancer and HPV Research
- Brain Metastases and Treatment
- Uterine Myomas and Treatments
Hôpital Tenon
2018-2025
Sorbonne Université
2018-2025
Assistance Publique – Hôpitaux de Paris
2018-2024
Laboratoire d’Imagerie Biomédicale
2024
Sorbonne Paris Cité
2021-2023
Hospital Universitario Reina Sofía
2011-2021
Hôpitaux Universitaires Paris-Ouest
2018-2021
Institut Gustave Roussy
2013-2019
Sorbonne University Abu Dhabi
2019
Université Paris-Saclay
2014-2017
There is a lack of information as to which molecular processes, present at diagnosis, favor tumour escape from standard-of-care treatments in cervical cancer (CC). RAIDs consortium (www.raids-fp7.eu), conducted prospectively monitored trial, [BioRAIDs (NCT02428842)] with the objectives generate high quality samples and assessments stratify patient populations identify patterns associated poor outcome.Between 2013 2017, collected prospective CC sample clinical dataset involving 419...
To investigate the prognostic value of leukocyte and neutrophil count as biomarkers in patients with locally advanced esophageal squamous cell carcinoma (SCC) undergoing exclusive chemoradiation.A total 126 were identified. Respectively, 33% 35% displayed baseline leukocytosis neutrophilia. Estimated 3-year OS PFS from chemoradiation completion 31% 25%, respectively. In univariate analysis, both neutrophilia associated worse OS, PFS, LRC (p < 0.01). multivariate remained an independent risk...
514 Background: Locoregional management of early stage breast cancer (BC) has evolved from maximal tolerable to minimal effective therapies. Significant advancements in radiation therapy (RT), such as limited target volumes and hypofractionation, have led accelerated partial irradiation (APBI). This study reports on toxicity cosmetic outcomes APBI post-menopausal women with unifocal pT1-N0-M0 invasive BC. Methods: The SHARE trial (NCT01247233) is a non-inferiority, multicenter, randomized...
Breast-conserving treatment (BCT) has been validated for breast cancer patients receiving adjuvant chemotherapy. Our objective was to evaluate the difference in loco-regional recurrence (LRR) rates between BCT and mastectomy radiation therapy after neo-adjuvant chemotherapy (NCT). A retrospective data base used identify all with undergoing NCT from 2002 2007. Patients initial metastatic disease were excluded this analysis. LRR compared those mastectomy. Individual variables associated...